P3394Carotid plaque neovascularization correlates to increased intraplaque blood-like tissue in acute coronary syndrome

2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
L E Mantella ◽  
K N Colledanchise ◽  
M F Hetu ◽  
M Weller ◽  
J E Herr ◽  
...  

Abstract Background The assessment of carotid plaque composition has attracted great interest as a tool to predict plaque vulnerability and subsequent risk of cardiovascular events. These vulnerable plaque lesions are characterized by the presence of intraplaque neovascularization (IPN). Previously, grayscale pixel ranges of ultrasound images have been correlated to various human tissue types. Thus, using these ranges, it is possible to assess the composition of atherosclerotic plaque non-invasively. Purpose This study sought to determine the relationship between carotid plaque composition and the degree of neovascularization in patients presenting with acute coronary syndrome (ACS), when compared to patients with stable angina. Methods A carotid focused vascular ultrasound was performed in 92 participants who had recently undergone coronary angiography due to stable angina or ACS. In 81 participants found to have atherosclerotic plaque in at least one carotid artery, plaque composition was assessed for tissue-like types by pixel distribution analysis: grayscale ranges 0–4 (blood), 8–26 (fat), 41–76 (muscle), 112–196 (fibrous), and 211–255 (calcium) (Figure 1). Participants also received microbubble contrast to assess IPN. IPN was graded based on the presence and location of microbubbles within each plaque (0, not visible; 1, peri-adventitial; 2, plaque core) and averaged to obtain an overall score. An independent t-test was used to compare continuous variables. Pearson pairwise correlations were used to assess associations between IPN and tissue composition. Results In the overall sample population, increased average IPN score correlated with increased plaque % blood tissue type (rho=0.28; p=0.01). Patients presenting with ACS (n=32) had increased neovascularization (IPN score of 1.47 vs 1.09; p=0.4), compared to patients with stable angina. In addition, ACS patients with an IPN score ≥1.25 had higher levels of plaque % blood (1.97% vs 0.75%; p=0.02).In ACS patients only, % blood increased with IPN score (r=0.34; p=0.06) and % fibrous tissue decreased with IPN score (r=−0.42; p=0.02). Figure 1 Conclusion The proportion of blood-like tissue in carotid plaque is associated with neovascularization and is increased in ACS patients. This may indicate hemorrhage within the plaque leading to rupture. Increased fibrous tissue may have a protective role, stabilizing the plaque when present. This data suggests that carotid plaque composition may be used as an imaging biomarker for cardiovascular risk, and its incorporation into routine screening practices may improve patient risk stratification. Acknowledgement/Funding CIHR CGS-Doctoral Award, Heart and Stroke Foundation of Canada, Canada Foundation for Innovation

2021 ◽  
Author(s):  
Ana I Fernandez ◽  
Javier Bermejo ◽  
Raquel Yotti ◽  
Miguel Ángel Martínez-Gonzalez ◽  
Alex Mira ◽  
...  

Abstract Background: Primary prevention trials have demonstrated that the traditional Mediterranean diet is associated with a reduction in cardiovascular mortality and morbidity. However, this benefit has not been proven for secondary prevention after an acute coronary syndrome (ACS). We hypothesized that a high-intensity Mediterranean diet intervention after an ACS decreases the vulnerability of atherosclerotic plaques by complex interactions between anti-inflammatory effects, microbiota changes and modulation of gene expression. Methods: The MEDIMACS project is an academically funded, prospective, randomized, controlled and mechanistic clinical trial designed to address the effects of an active randomized intervention with the Mediterranean diet on atherosclerotic plaque vulnerability, coronary endothelial dysfunction, and other mechanistic endpoints. One hundred patients with ACS are randomized 1:1 to a monitored high-intensity Mediterranean diet intervention or to standard-of-care arm. Adherence to diet is assessed in both arms using food frequency questionnaires and biomarkers of compliance. The primary endpoint is the change (from baseline to 12 months) in the thickness of the fibrous cap of a non-significant atherosclerotic plaque in a non-culprit vessel, as assessed by repeated optical-coherence-tomography intracoronary imaging. Indices of coronary vascular physiology and changes in gastrointestinal microbiota, immunological status, and protein and metabolite profiles will be evaluated as secondary endpoints. Discussion: The results of this trial will address the key effects of dietary habits on atherosclerotic risk and will provide initial data on the complex interplay of immunological, microbiome-, proteome- and metabolome-related mechanisms by which non-pharmacological factors may impact the progression of coronary atherosclerosis after an ACS.Trial registration: ClinicalTrials.gov, NCT03842319. Registered on 13 May 2019. https://clinicaltrials.gov/ct2/show/NCT03842319


2017 ◽  
Vol 1 ◽  
pp. 17-24
Author(s):  
Valeriia Vataha

The aim is to study the conditions of appearance and the features of course of the acute coronary syndrome (ACS) in patients with normal rates of lipid metabolism and to assess the influence of additional risk factors (uinary acid, C-reactive protein, fibrinogen) on the development of atherosclerotic process by assessment of surrogate markers of atherosclerosis the thickness of intima-media complex (TIMC) of carotid arteries (СА), the presence of atherosclerotic plaque (AP) in CA, the value of ankle-brachial index (ABI)) in patients with ACS without dyslipidemia (DLP). Materials and methods. The study included 66 patients without DLP (50 men and 16 women, the mean age - 53,7±10,6 years) with ACS, divided in groups depending on its forms: 1 group – patients with instable angina (IA), 2 group – patients with myocardium infraction (MI) without ST segment elevation and 3 group – patients with MI with ST segment elevation. The level of serum acid, C-reactive protein, fibrinogen in blood serum were detected and ultrasound examination of СА with detection of CA TIMC, presence of atherosclerotic plaque and measuring of arterial pressure on upper and low extremities with ABI calculation was carried out. Results. Among examined patients MI with ST segment elevation was diagnosed in 33 persons (50,0%); MI without ST segment elevation – in 18 (27,3%) and IA – in 15 (22,7%). The complicated ACS was observed in 20 (30,30%) persons. The value of CA TIMC among patients with MI with ST segment elevation was reliably higher than in patients with MI without ST segment elevation (р<0,001), and ABI was reliably lower in persons with MI and ST segment elevation (р<0,05) and IA (р<0,05) than in patients with MI without ST segment elevation. Correlative analysis demonstrated the interconnection between the levels of inflammation indicators (C-reactive protein, fibrinogen) in the blood serum and the value of CA TIMC and ABI. Conclusions. The persons without DLP need additional examination (detection of C-reactive protein, fibrinogen levels in blood serum, ultrasound of CA and detection of ABI) for more precise evaluation of ACS risk.


Circulation ◽  
2008 ◽  
Vol 118 (suppl_18) ◽  
Author(s):  
Elmir Omerovic ◽  
Truls Ramunddal ◽  
Lars Grip ◽  
Jan Boren ◽  
Goran Matejka ◽  
...  

Background Restenosis after percutaneous coronary intervention (PCI) was earlier thought to be a benign event clinically manifested as stable exertional angina. The aim of this prospective multicenter registry study was to investigate the incidence of acute coronary syndrome in patients with restenosis in Sweden. Methods Using data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR), we analyzed all registered cases of PCI for restenosis (in-stent, after balloon angioplasty) from 1995 to 2005 in Sweden. Both multivessel and single vessel interventions were included. Restenosis presentations were classified as: stable angina; unstable angina/non-STEMI; STEMI; and other reasons. As routine angiographic screening was not performed, restenosis episodes were defined clinically based on symptoms. Results We identified 6642 cases of restenosis in 2978 patients (4790 in men, 1852 in women). Restenosis presented in 39.7% of cases as stable angina, in 46.0% as unstable angina/non-STEMI, in 11.5% as STEMI and in 2.8% as other reasons. Cardiogenic shock was reported in 48 patients. Women had a higher incidence of unstable angina/non-STEMI compared with men (52.3% v. 43.6%) but a lower incidence of STEMI (9.6% v. 12.2%). The frequency of STEMI was lower with restenosis after balloon angioplasty v. in-stent restenosis (6.9% v. 13.8%), and after drug-eluting stents v. bare metal stents (7.9% v. 18.5%). Mortality rate was 1.7% at 30 days, 3.2% at 6 months and 4.6% at one year in patients with restenosis. These covariates were independent predictors of acute coronary syndrome: gender, age, vessel diameter, smoking, stent type, number of stents, treated vessel, previous stroke and previous infarction. Conclusion The majority of patients with coronary restenosis present either with acute MI or unstable angina requiring hospitalization and new interventions. Women may have a higher risk of developing acute coronary syndrome due to restenosis. Prevention of restenosis may be an important target for improvement of “hard” clinical outcomes in patients undergoing coronary revascularization.


2011 ◽  
Vol 75 (2) ◽  
pp. 383-390 ◽  
Author(s):  
Hirohiko Ando ◽  
Tetsuya Amano ◽  
Tatsuaki Matsubara ◽  
Tadayuki Uetani ◽  
Michio Nanki ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document